At NSCFF, many of our Faculty members are distinguished and prominent clinicians, researchers and educators. Several of our doctors have positions as professors at university medical schools where they are actively involved in the education and advancement of health care professionals, particularly in the field of Neurology. They are researchers, uncovering new information on your condition and educating others in their field on the best, most cutting-edge practices of care for your treatment.
Jack Burks, MD is a Clinical Professor in the Department of Neurology at the FIU Herbert Wertheim College of Medicine. An international leader in Multiple Sclerosis (MS), neurology, and chronic disease management, Dr. Burks has written and edited several textbooks on MS management and research, including Multiple Sclerosis: Diagnosis, Medical Management and Rehabilitation, and published hundreds of scientific articles and reviews. He has served as an Instructor in Neurology at Johns Hopkins University, an Assistant Professor of Neurology at the University of Colorado Health Sciences Center, an Associate Professor of Neurology and Clinical Associate Professor of Family Medicine at the University of Colorado School of Medicine, and a Clinical Professor of Medicine at the University of Nevada School of Medicine. He is also a medical and scientific consultant to many healthcare and non-profit organizations, presenting lectures to healthcare professionals, patients, and the public in over 40 countries on six continents.
Francisco Fernandez-Lima, PhD is an Assistant Professor at Florida International University with a research focus on the development of new-generation instrumentation and methodologies for biomedical and behavioral research. He is an NIH R00 fellow, a Bruker Daltonics Inc. Life Science division fellow, and the Director of the Advanced Mass Spectrometry Program at FIU. Dr. Fernandez-Lima’s group works on the development of new-generation mass spectrometry tools for the identification and localization of disease markers in biological tissues associated with Alzheimer’s Disease, Multiple Sclerosis, and Parkinson’s Disease. He has authored a large number of peer-reviewed scientific publications and actively presents his work at national and international conferences.
Alejandro Forteza, MD, is credited as the founder of the Miami-Dade Stroke Consortium and currently serves as one of its Board of Directors. The Consortium, formed in 1998 and incorporated in 2011 as a 501(c)(3) non-profit corporation, is a community effort of neurologists, neuro-radiologists, fire rescue departments, hospitals, and the American Heart/American Stroke Association. The mission of the Consortium is to increase awareness and improve stroke outcomes in Miami-Dade County. Dr. Forteza is board certified by the American Board of Neurology and Psychiatry. He received his Medical Degree from the Universidad Nacional de Córdoba, Facultad de Ciencias Medicas, in Córdoba, Argentina, and completed a four year internal medicine residency in Cordoba, Argentina and another in Danbury Hospital in Danbury CT; followed by a residency in Neurology and a fellowship in Cerebrovascular Diseases at the University of Miami. Dr. Forteza is currently the Director of Stroke Service at Kendall Regional Medical Center in Miami, Florida. He was formerly the Director of the Cerebrovascular Division at the University of Miami and Jackson Memorial Hospital from 1995 until 2009. He developed the largest and most comprehensive stroke service in the state of Florida, trained many stroke fellows and students and conducted a large number of clinical research projects. He has also been a Professor of Neurology at Florida International University, Associate Professor of Clinical Neurology at the University of Miami, as well as the Director of the Stroke and Cardiovascular Institute at the University of Miami. Dr. Forteza has published multiple research studies in renowned journals such as The Journal of Neuroimaging, Neuroepidemiology, Neurocritical Care, American Journal of Neuroradiology, Neurology Journal, Stroke and Circulation. He also has papers in New England Journal of Medicine and JAMA as a Researcher among a group of 15-20 Neurologists in the country. He is also a member of several national and international medical organizations and associations, such as the American Heart Association and National Stroke Association.
Jeffrey L. Horstmyer, MD, FAAN is the Founding Chairman of the Department of Neurology at the FIU Herbert Wertheim College of Medicine (2007-2014). Dr. Horstmyer completed his neurology residency training at Jackson Memorial Hospital/UM where he was appointed as the first administrative chief resident of neurology and was a fellow in neuromuscular neurology and electro-neurophysiology. He is committed to the advancement of medical education and serves as a Diplomate and Fellow of the American Academy of Neurology, a member of the American Association for the Advancement of Science and New York Academy of Science, and a member of the advisory board of Biomedical Engineering at FIU. Dr. Horstmyer is also the founder of the MS Center of Miami and the Miami Dade Stroke Consortium, non-profit organizations for the improvement of neurological care in Multiple Sclerosis and stroke.
Stuart H. Isaacson, MD is a Clinical Associate Professor in the Department of Neurology at the FIU Herbert Wertheim College of Medicine. Dr. Isaacson, who specializes in Parkinson’s disease and movement disorders, is in the forefront of Parkinson’s research as the Medical Director of the Parkinson’s Research and Education Foundation. He is also a fellow of the National Institute of health and his research focus is in developing new medications that halt the progression of Parkinson’s disease and serve to treat its symptoms.
Robert Zivadinov, MD, PhD is the Director of MRI Research at NSCFF and he is a Clinical Professor of Neurology at SUNY in Buffalo. He is also Director of the Residency Research and Fellowship Training Program, and Director of the Buffalo NeuroImaging Analysis Center. Dr. Zivadinov is a world class neuroimaging researcher with more than 200 papers and 400 abstracts published. He concentrates on the genetic, epidemiological, quantitative MRI diagnostics and therapeutic interventions for neurodegenerative diseases.